Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 19/20 | 0.39 |
| ▸ | HTR2A | P28223 | 17/20 | 0.39 |
| ▸ | DRD2 | P14416 | 16/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5639112 | 0.94 | HTR2C (0.40) | HTR2CHTR2ADRD2HTR2BRYR2 | |
| SCHEMBL5637023 | 0.93 | HTR2C (0.40) | HTR2CHTR2ADRD2HTR2BRYR2 | |
| SCHEMBL5636892 | 0.92 | HTR2C (0.38) | HTR2CHTR2ADRD2HTR2BRYR2 | |
| SCHEMBL5635088 | 0.91 | EPHX2 (0.37) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5638291 | 0.89 | HTR2C (0.39) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5638083 | 0.88 | HTR2C (0.40) | HTR2CHTR2ADRD2HTR2BRYR2 | |
| SCHEMBL5635056 | 0.88 | HTR2C (0.46) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5638939 | 0.87 | HTR2C (0.41) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5636867 | 0.87 | KDM4E (0.41) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5636495 | 0.87 | HTR2C (0.40) | HTR2CHTR2ADRD2HTR2BRYR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |